ANTALYA SUMMIT
PARTICIPANTS
< Back to Participants

Adrian Powell Thomas

Adrian Thomas, M.D., Vice President, Global Market Access and Global Public Health Adrian Thomas is Vice President, Global Market Access, Global Commercial Strategy Operations and Global Public Health (GPH), and has functional responsibility for Health Economics, Pharmaceutical Global Pricing, Patient-Reported Outcomes, Global Medical Affairs, and Public Health and Access. As co-leader of the GPH Organization, he is responsible for growing Janssen’s portfolio of pharmaceutical products and services for diseases that have a high public health impact. Adrian has a special interest in the fields of market access and pharmaceutical policy, public health and commercial strategy. He has also held numerous roles in risk management and safety, including Global Head of Benefit Risk Management and Chief Safety Officer for the pharmaceutical companies of Johnson &Johnson, Global Safety Officer for biologics and Head of Safety Surveillance and Epidemiology. Prior to joining J&J, Adrian held roles in regional medical affairs, drug development and product management for Schering-Plough and Eli Lilly. He is a clinical pharmacologist and vascular physician with experience in clinical trials design and methodology. Adrian is a Fellow of the Royal Australasian College of Physicians and the College of Medical Administrators. He received his Bachelor of Medicine and Bachelor of Surgery degrees from the University of Melbourne in Australia.